Stockreport

IMUNON Reports Compliance with Nasdaq Listing Requirements

Imunon, Inc.  (IMNN) 
PDF LAWRENCEVILLE, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) (“IMUNON” or the “Company”), a clinical-stage drug-development company focused on d [Read more]